A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase 2 Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis

Trial Profile

A Multicenter, Double-Blind, Randomized, Placebo- Controlled, Phase 2 Study to Evaluate Velusetrag Effects on Gastric Emptying in Subjects With Diabetic or Idiopathic Gastroparesis

Completed
Phase of Trial: Phase II

Latest Information Update: 19 May 2015

At a glance

  • Drugs Velusetrag (Primary)
  • Indications Diabetic gastroparesis; Gastroparesis
  • Focus Proof of concept; Therapeutic Use
  • Sponsors Theravance
  • Most Recent Events

    • 18 May 2015 Results published in a Theravance Biopharma media release.
    • 18 May 2015 According to a Theravance Biopharma media release, data from this study were presented at the Digestive Disease Week (DDW) 2015.
    • 31 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top